Video

Disposable ureteroscope reduces costs of care

Author(s):

Urology Times staff

Amy E. Krambeck, MD, discusses the findings of a recent 90-day trial of a single-use disposable ureteroscope.

Amy E. Krambeck, MD, discusses a recent Urology Practice paper, "Initial Experience With a Novel Single Use Disposable Ureteroscopy: A Prospective Single Arm 90-day Trial of the Axis Ureteroscope," for which she served as a study author. Krambeck is the Michael O. Koch Professor of Urology at Indiana University School of Medicine, Indianapolis.

More videos:

Gender disparity seen with renal cell carcinoma management​

Prolapse surgery outcomes compared in nursing home residents, community-dwelling residents​

Effect of an online opioid training course on prescription patterns for urologic surgeries​

Related Videos
Human kidney stones | Image Credit: © freshidea - stock.adobe.com
Thomas Chi, MD, MBA, answers a question during a Zoom video interview
Human kidney stones | Image Credit: © freshidea - stock.adobe.com
Thomas Chi, MD, MBA, answers a question during a Zoom video interview
Victoria S. Edmonds, MD, answers a question during a Zoom video interview
Human kidney stones | Image Credit: © freshidea - stock.adobe.com
DNA strand illustration | Image Credit: © Radomir Jovanovic - stock.adobe.com
Magnifying glass examining DNA | Image Credit: © Giovanni Cancemi - stock.adobe.com
Related Content
FDA grants rare pediatric disease designation to YOLT-203 for primary hyperoxaluria type 1
September 4th 2024

FDA grants rare pediatric disease designation to YOLT-203 for primary hyperoxaluria type 1

Hannah Clarke
YOLT-203 is currently being assessed in the early phase 1 YOLT-203-101 trial.
Why kidney stones will become more prevalent over time
February 17th 2022

Why kidney stones will become more prevalent over time

Urology Times staff
“The prevalence of kidney stones has increased over 80% over the last 30 years, and the epidemiology has changed such that it's beginning at a younger age now,” says Gregory Tasian, MD, MSc, MSCE.
Increasing thiazide doses linked to fewer kidney stone events
August 27th 2024

Increasing thiazide doses linked to fewer kidney stone events

Hannah Clarke
“What this means for patients is that thiazides remain an important option in the toolkit for preventing kidney stone recurrence,” says Ryan S. Hsi, MD, FACS.
Dr. Krambeck investigates efficacy of Trilogy and ShockPulse-SE lithotripters
September 9th 2021

Dr. Krambeck investigates efficacy of Trilogy and ShockPulse-SE lithotripters

Urology Times staff
“You have tradeoffs with every device that you use,” says Amy E. Krambeck, MD.
Data suggest Break Wave lithotripsy is safe, effective for urolithiasis
August 21st 2024

Data suggest Break Wave lithotripsy is safe, effective for urolithiasis

Hannah Clarke
Any stone fragmentation was achieved in 88% of patients.
Kari Tikkinen, MD, highlights the APPEAL trial of antibiotic prophylaxis prior to SWL
August 19th 2024

Kari Tikkinen, MD, highlights the APPEAL trial of antibiotic prophylaxis prior to SWL

Urology Times staff
"The great news is that we have now completed recruitment. We actually recruited more than 1700 patients," says Kari A.O. Tikkinen, MD, PhD.
© 2024 MJH Life Sciences

All rights reserved.